Optum joins CVS, Cigna in dropping Humira
(By Rylee Wilson for Becker’s Hospital Review) Optum Rx will join the other major pharmacy benefit managers and exclude Humira
Read More
Biosimilars drugs
What 5 recent studies found about Medicare Advantage
(By Rylee Wilson for Becker’s Hospital Review) Recent research on Medicare Advantage has tracked competition in local markets and investigated
Read MoreCareFirst sues J&J over alleged anticompetitive biosimilar tactics
(By Andrew Cass for Becker’s Hospital Review) CareFirst BlueCross BlueShield has filed a proposed class-action lawsuit accusing Johnson & Johnson
Read MoreSave Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice
(By Arthur Allen for KFF Health News) Tennessee last year spent $48 million on a single drug, Humira — about
Read MoreAbbVie’s blockbuster drug Humira finally loses its 20-year, $200 billion monopoly
(Leslie Walker and Dan Gorenstein for NPR) After 20 years and $200 billion in revenue, Humira — an injectable treatment
Read More